Episodes

  • The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review

    The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review
    Nov 6 2024
    Dr Tanios Bekaii-Saab from Mayo Clinic in Phoenix, Arizona, and Dr Philip A Philip from the Henry Ford Cancer Institute in Detroit, Michigan, discuss recent research presentations on the treatment of gastrointestinal cancers.
    Show more Show less
    1 hr and 2 mins
  • Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors

    Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors
    Oct 18 2024
    Dr Thierry Alcindor from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for desmoid tumors and review novel options for targeted therapy.
    Show more Show less
    59 mins
  • Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers

    Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers
    Sep 20 2024
    Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, summarize the treatment landscape for patients with biliary tract cancers and review recent advancements in the field.
    Show more Show less
    2 hrs and 15 mins
  • Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors

    Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
    Sep 19 2024
    Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.
    Show more Show less
    59 mins
  • Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

    Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers
    Sep 13 2024
    Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers.
    Show more Show less
    1 hr and 1 min
  • Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma

    Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma
    Sep 10 2024
    Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other sarcomas.
    Show more Show less
    1 hr and 15 mins
  • RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer

    RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer
    Jul 16 2024
    Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer.
    Show more Show less
    1 hr and 3 mins
  • Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer

    Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
    May 3 2024
    Prof Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer.
    Show more Show less
    1 hr